Article
MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential
15 Jan 2025
Abstract excerpt
Pancreatic cancer (PC) remains one of the most lethal malignancies, primarily due to its intrinsic resistance to conventional therapies. MicroRNAs (miRNAs), key regulators of gene expression, have been identified as crucial modulators of drug resistance mechanisms in this cancer type. This review synthesizes recent advancements in our understanding of how miRNAs influence treatment efficacy in PC. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
